Lytix Biopharma As

This study tested a two-step treatment for people with advanced soft tissue sarcoma that had stopped responding to standard therapy. First, a drug called LTX-315 was injected into a tumor to attract immune cells. Then, that tumor was removed, and the immune cells were grown in a …

This study tested a new drug combination for people with advanced melanoma that no longer responds to standard immunotherapy. The treatment involves injecting LTX-315 directly into tumors along with pembrolizumab, an immunotherapy drug given through the vein. The goal was to see …